According to Jasper Therapeutics's latest financial reports the company has S$96.22 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | S$97.37 M | -15.14% |
2023-12-31 | S$0.11 B | 123.78% |
2022-12-31 | S$51.27 M | -55.22% |
2021-12-31 | S$0.11 B | 336.31% |
2020-12-31 | S$26.24 M |